GENFIT (EPA:GNFT) GENFIT: Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
Transparency directive : regulatory news
13/11/2023 22:30